Technical Advisor： Yuzuru Ito （Associate Professor Department of Biophysics and Biochemistry)
Company Profile
Company Name
Curreio, Inc.
HQ Location
Room 357, South Clinical Research Laboratory, Tokyo University, 7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan, 113-8485
Representative
CEO Motoki Nakai
Establishment
August 2019
Capital
Approximately 400 million yen (including capital reserve)
Business Contents
Drug discovery and R & D business based on structural analysis using Cryo-EM
Legal Advisor
Anderson Mōri & Tomotsune
Shareholders
Beyond Next Ventures, T&D Innovation, Asahi Kasei Pharma Corporation, 3S Capital, U-Tokyo Entrepreneur Supporter’s Club, IKERUNippon Capital Partners, Ono Venture Investment, DOJIN CAPITAL, GEMSEKI, Etc.
Access
Office/Lab
Room 357, South Clinical Research Laboratory, Tokyo University, 7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan, 113-8485
Currently, in order to strengthen the alert for COVID-19 at the University of Tokyo,
please call our staff when you arrive at the South Clinical Research Building.
Inquiry
We accept consultations and joint research on structure-based drug discovery (SBDD).
If you are interested, please contact us from the inquiry page.
